SAEN
Genenta Science S.p.A.
Price Chart
Latest Quote
$0.65
-0.05 (-7.19%)
Current Price
| Previous Close | $0.70 |
| Open | $0.67 |
| Day High | $0.68 |
| Day Low | $0.56 |
| Volume | 158,601 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 48.22M |
| Total Debt | $8.52M |
| Cash Equivalents | $31.53M |
| Net Income | $-7.31M |
| Sector | Industrials |
| Industry | Conglomerates |
| Market Cap | $31.33M |
| EPS (TTM) | $-0.36 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-5.22M |
| Income | $-7.31M |
| Book/sh | $1.05 |
| Cash/sh | $0.58 |
| Employees | 9 |
Financial Ratios
| Quick Ratio | 13.90 |
| Current Ratio | 14.15 |
| Debt/Eq | 34.81 |
Returns & Margins
| ROA | -17.67% |
| ROE | -38.03% |
Ownership
| Insider Ownership | 43.49% |
| Institutional Ownership | 4.73% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 0.62 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 18.78M |
| Short Float | 0.24% |
| Short Ratio | 1.79 |
| Volatility | 0.77 |
Performance History
| Week | +4.84% |
| YTD | +4.17% |
| 10 Years | +4.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-11-05 | $0.65 | 158,600 |
| 2026-11-04 | $0.70 | 189,700 |
| 2026-11-03 | $0.99 | 337,500 |
| 2026-11-02 | $0.82 | 1,572,100 |
| 2026-10-30 | $0.62 | 67,200 |
| 2026-10-29 | $0.62 | 152,600 |
| 2026-10-28 | $0.61 | 42,000 |
| 2026-10-27 | $0.62 | 18,800 |
| 2026-10-26 | $0.62 | 28,900 |
About Genenta Science S.p.A.
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
đ° Latest News
No news articles available at the moment. Check back later for updates on SAEN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $7,410,773 | $10,957,592 | $13,166,807 | $12,393,662 |
| Other Income Expense | $-599,927 | $864,858 | $-248,868 | $2,838,339 |
| Other Non Operating Income Expenses | $12,856 | $594,415 | $-5,471 | $272,196 |
| Net Non Operating Interest Income Expense | $682,873 | $91,056 | $347,046 | $41,505 |
| Operating Expense | $7,410,773 | $10,957,592 | $13,166,807 | $12,393,662 |
| General And Administrative Expense | $4,381,549 | $5,556,566 | $5,901,135 | $6,402,233 |
| Total Other Finance Cost | - | - | $-347,046 | $-41,505 |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Net Interest Income | $682,873 | $91,056 | $347,046 | $41,505 |
| Interest Income | $682,873 | $91,056 | $347,046 | $41,505 |
| Normalized Income | $-6,715,044 | $-10,272,121 | $-12,825,232 | $-12,079,961 |
| Net Income From Continuing And Discontinued Operation | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Total Operating Income As Reported | $-7,410,773 | $-10,957,592 | $-13,166,807 | $-12,393,662 |
| Net Income Common Stockholders | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Net Income | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Net Income Including Noncontrolling Interests | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Net Income Continuous Operations | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Pretax Income | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Interest Income Non Operating | $682,873 | $91,056 | $347,046 | $41,505 |
| Operating Income | $-7,410,773 | $-10,957,592 | $-13,166,807 | $-12,393,662 |
| Per Share | ||||
| Diluted EPS | $-0.37 | $-0.55 | $-0.72 | $-0.53 |
| Basic EPS | $-0.37 | $-0.55 | $-0.72 | $-0.53 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,766,476 | $-11,178,071 | $-12,875,769 | $-14,952,914 |
| Total Unusual Items | $-612,783 | $270,443 | $-243,397 | $2,566,143 |
| Total Unusual Items Excluding Goodwill | $-612,783 | $270,443 | $-243,397 | $2,566,143 |
| Reconciled Depreciation | $31,514 | $49,964 | $47,641 | $6,890 |
| EBITDA (Bullshit earnings) | $-7,379,259 | $-10,907,628 | $-13,119,166 | $-12,386,771 |
| EBIT | $-7,410,773 | $-10,957,592 | $-13,166,807 | $-12,393,662 |
| Diluted Average Shares | $22,118,939 | $20,506,666 | $20,443,168 | $20,443,113 |
| Basic Average Shares | $22,118,939 | $20,506,666 | $20,443,168 | $20,443,113 |
| Diluted NI Availto Com Stockholders | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-612,783 | $270,443 | $-243,397 | $2,566,143 |
| Research And Development | $3,029,225 | $5,401,026 | $7,265,673 | $5,991,429 |
| Selling General And Administration | $4,381,549 | $5,556,566 | $5,901,135 | $6,402,233 |
| Other Gand A | $2,134,085 | $2,754,971 | $3,031,335 | $2,116,114 |
| Insurance And Claims | $23,360 | $20,360 | $24,589 | $1,410,063 |
| Salaries And Wages | $2,224,104 | $2,781,234 | $2,845,210 | $2,876,057 |
Fetched: 2026-11-05
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $24,509,752 | $14,022,787 | $22,929,252 | $34,943,515 |
| Total Assets | $35,786,455 | $16,635,611 | $25,078,156 | $37,524,251 |
| Total Non Current Assets | $2,143,147 | $393,913 | $1,224,203 | $1,926,262 |
| Other Non Current Assets | $5,059 | $20,137 | $236,301 | $47,614 |
| Non Current Accounts Receivable | $2,112,877 | $325,609 | $894,784 | $1,753,365 |
| Current Assets | $33,643,308 | $16,241,698 | $23,853,953 | $35,597,989 |
| Other Current Assets | $378,676 | $236,595 | $72,566 | $246,213 |
| Prepaid Assets | $232,627 | $172,803 | $462,637 | $162,371 |
| Receivables | $1,442,745 | $1,625,419 | $2,248,495 | $1,753,364 |
| Taxes Receivable | $1,442,745 | $1,625,419 | $2,248,495 | $1,753,364 |
| Cash Cash Equivalents And Short Term Investments | $31,589,260 | $14,206,880 | $21,070,255 | $33,436,041 |
| Cash And Cash Equivalents | $6,203,201 | $5,141,678 | $4,142,543 | $33,436,041 |
| Cash Financial | $6,203,201 | $5,141,678 | $4,142,543 | $33,436,041 |
| Current Deferred Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $2,328,951 | - | - | - |
| Total Debt | $8,532,151 | - | - | - |
| Long Term Debt And Capital Lease Obligation | $8,532,151 | - | - | - |
| Long Term Debt | $8,532,151 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $11,276,703 | $2,612,823 | $2,148,904 | $2,580,736 |
| Total Non Current Liabilities Net Minority Interest | $8,899,994 | $256,902 | $201,155 | $130,379 |
| Current Liabilities | $2,376,709 | $2,355,922 | $1,947,749 | $2,450,357 |
| Other Current Liabilities | $133,543 | $379,042 | $286,233 | $334,278 |
| Payables And Accrued Expenses | $2,243,166 | $1,976,880 | $1,661,516 | $2,116,079 |
| Payables | $2,030,743 | $558,799 | $522,795 | $1,339,964 |
| Accounts Payable | $1,693,712 | $356,672 | $331,023 | $1,169,402 |
| Other Non Current Liabilities | - | $1,300 | $16,378 | $30,544 |
| Equity | ||||
| Common Stock Equity | $24,509,752 | $14,022,787 | $22,929,252 | $34,943,515 |
| Total Equity Gross Minority Interest | $24,509,752 | $14,022,787 | $22,929,252 | $34,943,515 |
| Stockholders Equity | $24,509,752 | $14,022,787 | $22,929,252 | $34,943,515 |
| Gains Losses Not Affecting Retained Earnings | $186,860 | $99,816 | $259,390 | $0 |
| Other Equity Adjustments | $186,860 | $99,816 | $259,390 | - |
| Retained Earnings | $-70,233,808 | $-62,905,981 | $-52,904,303 | $-39,799,752 |
| Other | ||||
| Ordinary Shares Number | $26,295,795 | $20,525,043 | $20,443,225 | $20,443,113 |
| Share Issued | $26,295,795 | $20,525,043 | $20,443,225 | $20,443,113 |
| Tangible Book Value | $24,509,752 | $14,022,787 | $22,929,252 | $34,943,515 |
| Invested Capital | $33,041,903 | $14,022,787 | $22,929,252 | $34,943,515 |
| Working Capital | $31,266,600 | $13,885,776 | $21,906,205 | $33,147,632 |
| Total Capitalization | $33,041,903 | $14,022,787 | $22,929,252 | $34,943,515 |
| Capital Stock | $94,556,700 | $76,828,953 | $75,574,166 | $74,743,266 |
| Common Stock | $94,556,700 | $76,828,953 | $75,574,166 | $74,743,266 |
| Employee Benefits | $367,843 | $255,602 | $184,777 | $99,835 |
| Non Current Pension And Other Postretirement Benefit Plans | $367,843 | $255,602 | $184,777 | $99,835 |
| Current Accrued Expenses | $212,423 | $1,418,081 | $1,138,721 | $776,115 |
| Dueto Related Parties Current | $337,031 | $202,128 | $191,772 | $170,562 |
| Net PPE | $25,210 | $48,167 | $93,117 | $125,282 |
| Accumulated Depreciation | $-141,853 | $-110,339 | $-60,374 | $-13,628 |
| Gross PPE | $167,063 | $158,506 | $153,491 | $138,910 |
| Other Properties | $68,533 | $59,976 | $54,961 | - |
| Machinery Furniture Equipment | $98,530 | $98,530 | $98,530 | $138,910 |
| Other Short Term Investments | $25,386,060 | $9,065,203 | $16,927,712 | $0 |
| Additional Paid In Capital | - | - | $0 | $0 |
Fetched: 2026-11-05
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,715,839 | $-7,007,790 | $-12,589,848 | $-8,355,186 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,707,282 | $-7,002,776 | $-12,574,372 | $-8,324,807 |
| Cash Flow From Continuing Operating Activities | $-7,707,282 | $-7,002,776 | $-12,574,372 | $-8,324,807 |
| Operating Gains Losses | $112,241 | $70,825 | $84,942 | $101,397 |
| Investing Activities | ||||
| Capital Expenditure | $-8,557 | $-5,014 | $-15,476 | $-30,378 |
| Investing Cash Flow | $-16,321,329 | $7,724,233 | $-16,712,676 | $-30,378 |
| Cash Flow From Continuing Investing Activities | $-16,321,329 | $7,724,233 | $-16,712,676 | $-30,378 |
| Financing Activities | ||||
| Financing Cash Flow | $25,011,175 | $303,989 | $596 | $0 |
| Cash Flow From Continuing Financing Activities | $25,011,175 | $303,989 | $596 | $0 |
| Net Other Financing Charges | $16,594,611 | $303,989 | $596 | - |
| Issuance Of Capital Stock | - | - | $596 | $0 |
| Net Common Stock Issuance | - | - | $596 | $0 |
| Common Stock Issuance | - | - | $596 | $0 |
| Other | ||||
| Issuance Of Debt | $8,416,564 | $0 | $0 | - |
| End Cash Position | $6,203,201 | $5,141,678 | $4,142,543 | $33,436,041 |
| Beginning Cash Position | $5,141,678 | $4,142,543 | $33,436,041 | $41,791,226 |
| Effect Of Exchange Rate Changes | $78,959 | $-26,311 | $-7,045 | $0 |
| Changes In Cash | $982,564 | $1,025,446 | $-29,286,453 | $-8,355,186 |
| Net Issuance Payments Of Debt | $8,416,564 | $0 | $0 | - |
| Net Long Term Debt Issuance | $8,416,564 | $0 | $0 | - |
| Long Term Debt Issuance | $8,416,564 | $0 | $0 | - |
| Net Investment Purchase And Sale | $-16,312,772 | $7,729,247 | $-16,697,200 | $0 |
| Sale Of Investment | $20,905,416 | $26,111,430 | $0 | $0 |
| Purchase Of Investment | $-37,218,187 | $-18,382,183 | $-16,697,200 | $0 |
| Net PPE Purchase And Sale | $-8,557 | $-5,014 | $-15,476 | $-30,378 |
| Purchase Of PPE | $-8,557 | $-5,014 | $-15,476 | $-30,378 |
| Change In Working Capital | $-1,771,934 | $1,927,316 | $-468,631 | $269,663 |
| Change In Other Current Liabilities | $-246,798 | $77,731 | $-62,212 | $251,794 |
| Change In Other Current Assets | $-1,772,191 | $785,339 | $669,895 | $-480,200 |
| Change In Payables And Accrued Expense | $266,285 | $315,364 | $-454,563 | $955,356 |
| Change In Accrued Expense | $-1,205,658 | $279,360 | $362,606 | $-171,539 |
| Change In Payable | $1,471,944 | $36,004 | $-817,169 | $1,126,895 |
| Change In Account Payable | $1,471,944 | $36,004 | $-817,169 | $1,126,895 |
| Change In Prepaid Assets | $-19,230 | $748,881 | $-621,751 | $-457,288 |
| Stock Based Compensation | $1,133,137 | $950,797 | $830,304 | $811,059 |
| Unrealized Gain Loss On Investment Securities | $115,587 | $0 | $0 | - |
| Depreciation Amortization Depletion | $31,514 | $49,964 | $47,641 | $6,890 |
| Depreciation And Amortization | $31,514 | $49,964 | $47,641 | $6,890 |
| Depreciation | $31,514 | $49,964 | $47,641 | $6,890 |
| Pension And Employee Benefit Expense | $112,241 | $70,825 | $84,942 | $65,474 |
| Net Income From Continuing Operations | $-7,327,827 | $-10,001,678 | $-13,068,629 | $-9,513,818 |
| Net Foreign Currency Exchange Gain Loss | - | $0 | $0 | $35,923 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Other Non Cash Items | - | - | - | $35,923 |
Fetched: 2026-11-05